Predictive value of serum βHCG level in ectopic pregnancy: A cross sectional study

Abstract Background and Aims Ectopic pregnancy (EP) is a potentially life‐threatening emergency. We investigate the predictive value of serum βHCG level and it's changes from the baseline to the 4th and 7th days after single dose (SD) methotrexate (MTX) treatment in successful treatment of tuba...

Full description

Bibliographic Details
Main Authors: Mandana Mansour Ghanaie, Sanaz Hoshyarmanesh, Seyedeh Maryam Asgari, Seyed Mohammad Asgari Galebin, Fereshteh Fakor
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Health Science Reports
Subjects:
Online Access:https://doi.org/10.1002/hsr2.1442
_version_ 1797672478034624512
author Mandana Mansour Ghanaie
Sanaz Hoshyarmanesh
Seyedeh Maryam Asgari
Seyed Mohammad Asgari Galebin
Fereshteh Fakor
author_facet Mandana Mansour Ghanaie
Sanaz Hoshyarmanesh
Seyedeh Maryam Asgari
Seyed Mohammad Asgari Galebin
Fereshteh Fakor
author_sort Mandana Mansour Ghanaie
collection DOAJ
description Abstract Background and Aims Ectopic pregnancy (EP) is a potentially life‐threatening emergency. We investigate the predictive value of serum βHCG level and it's changes from the baseline to the 4th and 7th days after single dose (SD) methotrexate (MTX) treatment in successful treatment of tubal EP. It is important for early diagnosis of EP. Methods In this cross‐sectional study, 690 women with tubal EP and under treatment with SD MTX were evaluated. Successful and failed groups were analyzed on the baseline, 4th and 7th days of MTX treatment. Data were analyzed using SPSS22 software. All p values of less than 0/05 were considered satistically significant. Results SD MTX treatment was successful in 584 (84.7%) patients. The mean baseline ßHCG value was 882.35 ± 430.76 in the successful group and 1083.99 ± 1080.25 in the failed group. There was a 19.53% decrease in ßHCG values between the baseline and 4th days in the successful group and a 12.94% increase in the failed group (p < 0.001). On days baseline, 4 and 7; receiver operating characteristic curve analysis's value was 504.5, 429, 279 for cut off; 58%, 73%, 81% for sensitivity and 51%, 52%, 55% for specificity, respectively. Conclusion A decrease in the ßHCG value and/or a cut‐off decrease of 59.9% on the baseline, 4th day and 81.6% between the baseline and 7th days, can predict the successful treatment of tubal EP with SD MTX.
first_indexed 2024-03-11T21:30:39Z
format Article
id doaj.art-411798e3b92f462ba34873b61f0a6fdc
institution Directory Open Access Journal
issn 2398-8835
language English
last_indexed 2024-03-11T21:30:39Z
publishDate 2023-09-01
publisher Wiley
record_format Article
series Health Science Reports
spelling doaj.art-411798e3b92f462ba34873b61f0a6fdc2023-09-27T09:16:35ZengWileyHealth Science Reports2398-88352023-09-0169n/an/a10.1002/hsr2.1442Predictive value of serum βHCG level in ectopic pregnancy: A cross sectional studyMandana Mansour Ghanaie0Sanaz Hoshyarmanesh1Seyedeh Maryam Asgari2Seyed Mohammad Asgari Galebin3Fereshteh Fakor4Department of Obstetrics & Gynecology, Reproductive Health Research Center, Alzahra Hospital, School of Medicine Guilan University of Medical Sciences Rasht IranDepartment of Obstetrics & Gynecology, Reproductive Health Research Center, Alzahra Hospital, School of Medicine Guilan University of Medical Sciences Rasht IranGuilan University of Medical Sciences Rasht IranGuilan University of Medical Sciences Rasht IranDepartment of Obstetrics & Gynecology, Reproductive Health Research Center, Alzahra Hospital, School of Medicine Guilan University of Medical Sciences Rasht IranAbstract Background and Aims Ectopic pregnancy (EP) is a potentially life‐threatening emergency. We investigate the predictive value of serum βHCG level and it's changes from the baseline to the 4th and 7th days after single dose (SD) methotrexate (MTX) treatment in successful treatment of tubal EP. It is important for early diagnosis of EP. Methods In this cross‐sectional study, 690 women with tubal EP and under treatment with SD MTX were evaluated. Successful and failed groups were analyzed on the baseline, 4th and 7th days of MTX treatment. Data were analyzed using SPSS22 software. All p values of less than 0/05 were considered satistically significant. Results SD MTX treatment was successful in 584 (84.7%) patients. The mean baseline ßHCG value was 882.35 ± 430.76 in the successful group and 1083.99 ± 1080.25 in the failed group. There was a 19.53% decrease in ßHCG values between the baseline and 4th days in the successful group and a 12.94% increase in the failed group (p < 0.001). On days baseline, 4 and 7; receiver operating characteristic curve analysis's value was 504.5, 429, 279 for cut off; 58%, 73%, 81% for sensitivity and 51%, 52%, 55% for specificity, respectively. Conclusion A decrease in the ßHCG value and/or a cut‐off decrease of 59.9% on the baseline, 4th day and 81.6% between the baseline and 7th days, can predict the successful treatment of tubal EP with SD MTX.https://doi.org/10.1002/hsr2.1442ectopic pregnancyhuman chorionic gonadotropin (ΒHCG)methotrexatetreatmenttubal pregnancy
spellingShingle Mandana Mansour Ghanaie
Sanaz Hoshyarmanesh
Seyedeh Maryam Asgari
Seyed Mohammad Asgari Galebin
Fereshteh Fakor
Predictive value of serum βHCG level in ectopic pregnancy: A cross sectional study
Health Science Reports
ectopic pregnancy
human chorionic gonadotropin (ΒHCG)
methotrexate
treatment
tubal pregnancy
title Predictive value of serum βHCG level in ectopic pregnancy: A cross sectional study
title_full Predictive value of serum βHCG level in ectopic pregnancy: A cross sectional study
title_fullStr Predictive value of serum βHCG level in ectopic pregnancy: A cross sectional study
title_full_unstemmed Predictive value of serum βHCG level in ectopic pregnancy: A cross sectional study
title_short Predictive value of serum βHCG level in ectopic pregnancy: A cross sectional study
title_sort predictive value of serum βhcg level in ectopic pregnancy a cross sectional study
topic ectopic pregnancy
human chorionic gonadotropin (ΒHCG)
methotrexate
treatment
tubal pregnancy
url https://doi.org/10.1002/hsr2.1442
work_keys_str_mv AT mandanamansourghanaie predictivevalueofserumbhcglevelinectopicpregnancyacrosssectionalstudy
AT sanazhoshyarmanesh predictivevalueofserumbhcglevelinectopicpregnancyacrosssectionalstudy
AT seyedehmaryamasgari predictivevalueofserumbhcglevelinectopicpregnancyacrosssectionalstudy
AT seyedmohammadasgarigalebin predictivevalueofserumbhcglevelinectopicpregnancyacrosssectionalstudy
AT fereshtehfakor predictivevalueofserumbhcglevelinectopicpregnancyacrosssectionalstudy